Tirzepatide demonstrates superior weight loss results in clinical trials, with patients losing 15-22% of body weight compared to 10-15% with semaglutide, though both medications are highly effective GLP-1 options
Dixon, S
Ozempic for type 2 diabetes typically qualifies without extra documentation, while weight loss use may require additional approval
If you have health issues or take medications, it is important to talk to a healthcare professional before starting any new supplement
The findings, in Cell Host & Microbe , suggest extra benefits from this new class of drugs, beyond their metabolic effects on diabetes and obesity
It attracts immune cells (macrophages and mast cells) to the site of damage, suppresses inflammatory cytokines (like TNF-alpha), and accelerates the closure of difficult-to-treat wounds, including diabetic ulcers and ischemic injuries